Schulte Spencer S, Fernandez Isaac, Van Tienderen Richard, Reich Michael S, Adler Adam, Nguyen Mai P
Department of Orthopaedic Surgery and Rehabilitation, Texas Tech University Health Sciences Center El Paso, El Paso, TX.
Department of Orthopaedic Surgery and Rehabilitation, William Beaumont Army Medical Center, El Paso, TX.
J Orthop Trauma. 2020 Oct;34(10):533-538. doi: 10.1097/BOT.0000000000001795.
To determine the effect of the fascia iliaca block (FIB) on patients undergoing surgery for hip fractures.
Prospective, randomized controlled trial.
Level I trauma center.
PATIENTS/PARTICIPANTS: Patients (N = 97) undergoing surgery for hip fractures were prospectively randomized to receive either a perioperative FIB (FIB group) or no block (control group) from February 2018 to April 2019.
Visual analog scale (VAS) score, morphine milligram equivalents, and postoperative ambulatory distance.
Fifty-seven patients were randomized to the FIB group, and 40 patients were randomized to the control group. Eighteen patients crossed over from the FIB to the control group, and 12 patients crossed over from the control to the FIB group. In the intent-to-treat analysis, demographic data, mechanism of injury, radiographic fracture classification, and surgical procedure were similar between the 2 groups. The FIB group consumed fewer morphine milligram equivalents before surgery (13 vs. 17, P = 0.04), had a trend toward an improved visual analog scale score on postoperative day 2 (0 vs. 2 P = 0.06), and walked a farther distance on postoperative day 2 (25' vs. 2', P = 0.09). A greater proportion of the FIB group were discharged home (50.9% vs. 32.5%, P = 0.05). There were no differences in opioid-related, block-related, or medical complications between groups. In the as-treated and per-protocol analyses, there were no significant differences.
A single perioperative FIB for patients with hip fractures undergoing surgery may decrease opioid consumption and increase the likelihood that a patient is discharged home.
Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
确定髂筋膜阻滞(FIB)对接受髋部骨折手术患者的影响。
前瞻性随机对照试验。
一级创伤中心。
患者/参与者:2018年2月至2019年4月期间,前瞻性随机选取97例接受髋部骨折手术的患者,分为围手术期接受FIB组(FIB组)或不进行阻滞组(对照组)。
视觉模拟评分(VAS)、吗啡毫克当量及术后行走距离。
57例患者被随机分配至FIB组,40例患者被随机分配至对照组。18例患者从FIB组转至对照组,12例患者从对照组转至FIB组。在意向性分析中,两组间的人口统计学数据、损伤机制、影像学骨折分类及手术方式相似。FIB组术前消耗的吗啡毫克当量较少(13 vs. 17,P = 0.04),术后第2天视觉模拟评分有改善趋势(0 vs. 2,P = 0.06),术后第2天行走距离更远(25' vs. 2',P = 0.09)。FIB组更多患者出院回家(50.9% vs. 32.5%,P = 0.05)。两组间在阿片类药物相关、阻滞相关或医疗并发症方面无差异。在实际治疗分析和符合方案分析中,无显著差异。
对于接受手术的髋部骨折患者,单次围手术期FIB可能减少阿片类药物的消耗,并增加患者出院回家的可能性。
治疗性二级证据。有关证据水平的完整描述,请参阅作者指南。